It's amazing that I sold 40% of my shares at $2.12 a long time ago when it more than doubled in a day on some preclinical news. That was at the beginning of the current/recent small cap biotech boom. I did that to lower the impact ENMD was having on my overall portfolio even though as a trade it seemed stupid as the stock took off. I of course hoped the stock would take off since I'm still holding the 60% I didn't sell. Now to my shock it's becomming more possible that sale at $2.12 is beginning to threaten to actually be a good long term trade. I certainly hope it doesn't reach that point.
Market Data 
Markets 
AI
